secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001493152-24-029978
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics raises $2.1M via exercise of warrants, issues new warrants for 1.56M shares
--------------------------------------------------------------------------------

- Existing warrant holders exercised 781,251 shares at $2.43/share, yielding ~$2.1M gross proceeds.
- Company issued new unregistered warrants to purchase 1,562,502 shares at $2.00/share (five-year and 18-month terms).
- H.C. Wainwright acted as exclusive placement agent; fees include 7.0% cash fee and placement agent warrants.
- Net proceeds to fund clinical trials, patent portfolio, and working capital.
- Inducement transaction expected to close August 2, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224029978/0001493152-24-029978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224029978/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-029978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer